NINE MASTS CAPITAL Ltd

Position in APGE — Apogee Therapeutics, Inc.

CIK 1569356 CENTRAL, K3

Position in APGE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,247,662

New position

Shares Held

9,400

first reported quarter

Ownership

0.012%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#171

of 281 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NINE MASTS CAPITAL Ltd holds $2,069,717 across 4 Biotechnology names. APGE ranks #1 (60.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc. This page	9,400	$1,247,662
2	VERA	Vera Therapeutics, Inc.	9,434	$404,812
3	INBX	Inhibrx Biosciences, Inc.	3,000	$284,250
4	ABVX	Abivax S.A.	998	$132,993

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,247,662	9,400	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.